Novel non-steroidal/non-anilide type androgen antagonists with an isoxazolone moiety

被引:113
作者
Ishioka, T
Kubo, A
Koiso, Y
Nagasawa, K
Itai, A
Hashimoto, Y
机构
[1] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan
[2] Key Mol Inc, Inst Med Mol Design, Bunkyo Ku, Tokyo 1130033, Japan
关键词
D O I
10.1016/S0968-0896(01)00421-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
3-Substitutcd (Z)-4-(4-N,N-dialkylaminophenylmethylene)-5(4H)-isoxazolones and related compounds were designed and prepared as candidates for structurally novel androgen antagonists. Several compounds showed potent anti-androgenic activity as assessed by nuclear androgen receptor binding assay and growth inhibition assay using androgen-dependent Shionogi carcinoma cells SC-3. They were approximately 10-220 times more potent than flutamide in these assay systems, They also showed anti-androgenic activity toward prostate tumor cell line LNCaP, which has an aberrant nuclear androgen receptor. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1555 / 1566
页数:12
相关论文
共 33 条
[1]   Mouse fibroblast growth factor 10: cDNA cloning, protein characterization, and regulation of mRNA expression [J].
Beer, HD ;
Florence, C ;
Dammeier, J ;
McGuire, L ;
Werner, S ;
Duan, DR .
ONCOGENE, 1997, 15 (18) :2211-2218
[2]   THE USE OF DIMETHYLFORMAMIDE AS A FORMYLATION REAGENT [J].
CAMPAIGNE, E ;
ARCHER, WL .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1953, 75 (04) :989-991
[3]   A synthesis of arylidene isoxazolones [J].
Donleavy, JJ ;
Gilbert, EE .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1937, 59 :1072-1076
[4]  
Eyrolles L., 1992, MED CHEM RES, V2, P361
[5]   Synthesis and biological activity of a novel series of nonsteroidal, peripherally selective androgen receptor antagonists derived from 1,2-dihydropyridino[5,6-g]quinolines [J].
Hamann, LG ;
Higuchi, RI ;
Zhi, L ;
Edwards, JP ;
Wang, XN ;
Marschke, KB ;
Kong, JW ;
Farmer, LJ ;
Jones, TK .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (04) :623-639
[6]   Discovery of a potent, orally active, nonsteroidal androgen receptor agonist: 4-ethyl-1,2,3,4-tetrahydro-6(trifluoromethyl)-8-pyridono[5,6-g]-quinoline (LG121071) [J].
Hamann, LG ;
Mani, NS ;
Davis, RL ;
Wang, XN ;
Marschke, KB ;
Jones, TK .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (02) :210-212
[7]  
Hashimoto Y, 2000, RRD ORG CHEM, V4, P87
[8]  
HASHIMOTO Y, 1991, CELL BIOL REV, V25, P209
[9]   Structural development of biological response modifiers based on thalidomide [J].
Hashimoto, Y .
BIOORGANIC & MEDICINAL CHEMISTRY, 2002, 10 (03) :461-479
[10]   RETINOBENZOIC ACIDS AND NUCLEAR RETINOIC ACID RECEPTORS [J].
HASHIMOTO, Y .
CELL STRUCTURE AND FUNCTION, 1991, 16 (02) :113-123